Antimalarial drug resistance-is it time to re-evaluate Plasmodium falciparum orthologous genes?

Lancet Microbe. 2022 Jul;3(7):e472-e473. doi: 10.1016/S2666-5247(22)00118-5. Epub 2022 May 20.

Authors

Aamer Ali Khattak¹, Usman Ayub Awan², Muhammad Faisal Nadeem³, Adnan Yaqoob³, Shehrish Kamran⁴

Affiliations

¹ Department of Medical Laboratory Technology, The University of Haripur, Haripur 22620, Pakistan. Electronic address: amir.khattak@hotmail.com.
² Department of Medical Laboratory Technology, The University of Haripur, Haripur 22620, Pakistan.
³ Department of Biochemistry & Biotechnology, University of Gujrat, Gujrat, Pakistan.
⁴ Department of Life Sciences, School of Science, University of Management and Technology, Lahore, Pakistan.

No abstract available

MeSH terms

Antimalarials* / pharmacology
Drug Resistance / genetics
Folic Acid Antagonists* / therapeutic use
Humans
Malaria, Falciparum* / drug therapy
Plasmodium falciparum / genetics

Substances

Antimalarials
Folic Acid Antagonists